XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
Common Stock
Additional Paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Series A convertible preferred stock
Series B convertible preferred stock
Series C convertible preferred stock
Total
Temporary equity, beginning balance at Dec. 31, 2018         $ 6,483,044 $ 49,742,942 $ 56,364,645  
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2018         612,446 7,235,969 4,712,698  
Increase (Decrease) in Temporary Equity                
Issuance of convertible preferred stock, net of issuance costs             $ 5,598,362  
Issuance of convertible preferred stock (in shares)             467,179  
Temporary equity, ending balance at Mar. 31, 2019         $ 6,483,044 $ 49,742,942 $ 61,963,007  
Temporary Equity, Ending Balance (in shares) at Mar. 31, 2019         612,446 7,235,969 5,179,877  
Equity, beginning balance at Dec. 31, 2018 $ 127,091 $ 19,666,588 $ (8,761,325) $ (62,468,456)       $ (51,436,102)
Equity, Beginning Balance (in shares) at Dec. 31, 2018 1,155,366              
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options $ 2,883 20,235           23,118
Exercise of stock options (in shares) 26,207              
Stock based compensation   97,946           97,946
Foreign currency translation     (2,031,175)         (2,031,175)
Net loss       (3,475,202)       (3,475,202)
Equity, ending balance at Mar. 31, 2019 $ 129,974 19,784,769 (10,792,500) (65,943,658)       (56,821,415)
Equity, Ending Balance (in shares) at Mar. 31, 2019 1,181,573              
Equity, beginning balance at Dec. 31, 2019 $ 21,023 226,284,548 (11,533,778) (90,528,263)       124,243,530
Equity, Beginning Balance (in shares) at Dec. 31, 2019 21,022,752              
Increase (Decrease) in Stockholders' Equity                
Exercise of stock options $ 32 29,491           29,523
Exercise of stock options (in shares) 32,090              
Stock based compensation   905,471           905,471
Foreign currency translation     (2,424,653)         (2,424,653)
Net loss       (9,400,257)       (9,400,257)
Equity, ending balance at Mar. 31, 2020 $ 21,055 $ 227,219,510 $ (13,958,431) $ (99,928,520)       $ 113,353,614
Equity, Ending Balance (in shares) at Mar. 31, 2020 21,054,842